Literature DB >> 24515917

Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma?

Alvaro Sanabria1, Carl E Silver, Kerry D Olsen, Jesus E Medina, Marc Hamoir, Vinidh Paleri, Vanni Mondin, Alessandra Rinaldo, Juan P Rodrigo, Carlos Suárez, Carsten C Boedeker, Michael L Hinni, Luiz P Kowalski, Afshin Teymoortash, Jochen A Werner, Robert P Takes, Alfio Ferlito.   

Abstract

Among patients with head and neck squamous cell carcinoma with a negative neck who are initially treated with (chemo)radiotherapy, a number of cases will recur locally without obvious neck recurrence. There is little information available as to the most efficacious management of the neck in these cases. We have reviewed the literature to see what conclusions can be drawn from previous reports. We conducted a bibliography search on MEDLINE and EMBASE databases. Studies published in the English language and those on squamous cell carcinoma of the oral cavity, nasopharynx, oropharynx, larynx and hypopharynx were included. Data related to neck management were extracted from the articles. Twelve studies satisfied the inclusion criteria. Five studies reported only one treatment plan (either neck dissection or observation), while the others compared neck dissection to observation. The rate of occult metastases ranged from 3.4 to 12 %. The studies included a variable distribution of primary sites and stages of the recurrent primary tumors. The risk of occult neck node metastasis in a clinically rN0 patient correlated with tumor site and T stage. Observation of the neck can be suggested for patients with T1-2 glottic tumors, who recurred with less advanced tumors (rT1-2). For patients with more advanced laryngeal recurrences or recurrence at other high-risk sites, neck dissection could be considered for the rN0 patient, particularly if the neck was not included in the previous radiation fields.

Entities:  

Mesh:

Year:  2014        PMID: 24515917     DOI: 10.1007/s00405-014-2893-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  35 in total

1.  Incidence of subclinical nodal disease at the time of salvage surgery for locally recurrent head and neck cancer initially treated with definitive radiation therapy.

Authors:  Eda Yirmibesoglu; David Fried; Carol Shores; Julian Rosenman; Mark Weissler; Trevor Hackman; Bhishamjit S Chera
Journal:  Am J Clin Oncol       Date:  2013-10       Impact factor: 2.339

2.  Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy.

Authors:  E Esteller; M C Vega; M López; M Quer; X León
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-19       Impact factor: 2.503

3.  Prognostic factors and outcome in craniofacial surgery for malignant cutaneous tumors involving the anterior skull base.

Authors:  F L Dias; G M Sá; J Kligerman; J Nogueira; M L Galvão; R A Lima
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-07

4.  Recurrence rates after selective neck dissection in the N0 irradiated neck.

Authors:  Michael A Fritz; Ramon M Esclamado; Robert R Lorenz; Benjamin G Wood; Pierre Lavertu; Marshall Strome
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-03

5.  Elective neck dissection during salvage laryngectomy.

Authors:  Mike Yao; Jeremy C Roebuck; F Christopher Holsinger; Jeffery N Myers
Journal:  Am J Otolaryngol       Date:  2005 Nov-Dec       Impact factor: 1.808

6.  Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck.

Authors:  Géke B Flach; Martina A Broglie; Annelies van Schie; Elisabeth Bloemena; C René Leemans; Remco de Bree; Sandro J Stoeckli
Journal:  Oral Oncol       Date:  2011-09-15       Impact factor: 5.337

7.  Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Authors:  Isaac A Bohannon; Renee A Desmond; Lisa Clemons; J Scott Magnuson; William R Carroll; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2010-01       Impact factor: 3.325

8.  Radiotherapy in N0 head and neck cancer patients.

Authors:  J P Bataini
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

9.  Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.

Authors:  Naveed Basheeth; Gerard O'Leary; Patrick Sheahan
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-08-01       Impact factor: 6.223

10.  Results of surgical salvage for radiation failures of laryngeal carcinoma.

Authors:  A P Yuen; W I Wei; C M Ho
Journal:  Otolaryngol Head Neck Surg       Date:  1995-03       Impact factor: 5.591

View more
  4 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

3.  Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation.

Authors:  Mischa de Ridder; Pieter D de Veij Mestdagh; Joris B W Elbers; Arash Navran; Charlotte L Zuur; Ludi E Smeele; Abrahim Al-Mamgani
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-10       Impact factor: 2.503

4.  Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  G Pedemonte; E Esteller; J-C Villatoro; J-M Costa; C Valero; M Quer; X León
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.